COMMENT CBER issued to Sanofi Pasteur an eleven page, 32 Observation Form FDA 483 following an audit of their Toronto, Canada facilities.  The dates of inspection encompassed the time frame of  April 10 - 25, 2012.  CBER previously published the Warning Letter regarding this subject which was initially noted within this Blog earlier in the week.  The most significant … [Read more...]